Loading viewer...
investor_presentation
Format: PDF investor_presentation
2018 Full Year Results 15 A ugust 2018CSL Limited CEO –Paul Perreault CFO –David Lamont
2018 Full Year Results
15 A ugust 2018CSL Limited
CFO –David LamontLegal Notice
| Driven by Our Promise™Forward looking statements
The materials inthispresentation speak only asofthedate ofthese materials, andinclude forward looking statements about CSL Limited anditsrelated bodies
corporate (CSL) financial results andestimates, business prospects andproducts inresearch, allofwhich involve substantial risks anduncertainties, many ofwhich
areoutside thecontrol of,andareunknown to,CSL.Youcanidentify these forward looking statements bythefactthatthey usewords such as“anticipate,” “estimate,”
“expect,” “project,” “intend,” “plan,”“believe,” “target,” “may,”“assume,” andother words andterms ofsimilar meaning inconnection with anydiscussion offuture
operating orfinancial performance .Factors thatcould cause actual results todiffer materially include :thesuccess ofresearch anddevelopment activities, decisions
byregulatory authorities regarding approval ofourproducts aswell astheir decisions regarding label claims ;competitive developments affecting ourproducts ;the
ability tosuccessfully market new and existing products ;difficulties ordelays inmanufacturing ;trade buying patterns and fluctuations ininterest and currency
exchange rates ;legislation orregulations thataffect product production, distribution, pricing, reimbursement, access ortax;acquisitions anddivestments ;research
collaborations ;litigation orgovernment investigations, andCSL’s ability toprotect itspatents and other intellectual property .The statements being made inthis
presentation donotconstitute anoffer tosell,orsolicitation ofanoffer tobuy, anysecurities ofCSL.
Norepresentation, warranty orassurance (express orimplied) isgiven ormade inrelation toanyforward looking statement byanyperson (including CSL) .In
particular, norepresentation, warranty orassurance (express orimplied) isgiven inrelation toanyunderlying assumption orthatanyforward looking statement willbe
achieved .Actual future events may vary materially from theforward looking statements andtheassumptions onwhich theforward looking statements arebased .
Subject toanycontinuing obligations under applicable laworanyrelevant listing rules oftheAustralian Securities Exchange, CSL disclaims anyobligation or
undertaking todisseminate anyupdates orrevisions toanyforward looking statements inthese materials toreflect anychange inexpectations inrelation toany
forward looking statements oranychange inevents, conditions orcircumstances onwhich anysuch statement isbased .Nothing inthese materials shall under any
circumstances create animplication thatthere hasbeen nochange intheaffairs ofCSL since thedate ofthese materials .
Except where otherwise noted, brand names designated bya™or®throughout thispresentation aretrademarks either owned byand/or licensed toCSL orits
2Delivering on Strategy
| Driven by Our Promise™
•IDELVION®exceeded forecast
•Specialty Products +24%1
-KCENTRA®& HAEGARDA®
•Exercised option to acquire
100% of Chinese fractionator
Preview truncated — download the full document for the complete content.
CSL Limited Capital Markets Day 2023
investor_presentationinvestor_presentation
106 Pages
investor_presentation
Genmab